longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Susan G. Komen® and AstraZeneca Partnership to Make Patient Navigation Available to All

Unusual Whales
Sep 14, 2026 at 01:06 PM
In Dallas, Susan G. Komen®, a prominent breast cancer organization, has revealed a collaboration with AstraZeneca to integrate patient navigation into the national healthcare system. This initiative aims to assist patients in overcoming obstacles, ensuring timely treatment, decreasing stress, and enhancing adherence to cancer care plans. Through the Navigation Infrastructure Collaboration, Komen and AstraZeneca will work towards bolstering patient navigation across the country by creating necessary evidence, infrastructure, and scalability.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…
  • Jul 29, 2025 at 07:44 AMStrong sales of anti-cancer drugs, AstraZeneca's Q2 revenue increased by 12% year-on-year, exceeding expectations | Fina…

Related Stocks

AstraZeneca

AstraZeneca

USAZN

+2.00%

AstraZeneca PLC

AstraZeneca PLC

UKAZN

LongbridgeAI